In just a few years, Switzerland has fallen from first to fifth place in the Global Competitiveness Index. The country is also losing ground in various subindexes, such as that for information and communication technologies, where it ranks 15th. Other studies highlight further weaknesses. For example, Switzerland is at the back of the midfield in terms of the availability of electronic patient data and the associated regulatory framework. However, the country still sits proudly at the top of the Global Innovation Index.
In 2012, Switzerland was regarded as the most politically stable country in the world. Today it is not even among the leaders. This fall in stability is also reducing legal and planning certainty, which, given its long-term investment horizons, is in turn reducing the pharmaceutical industry’s willingness to set up new operations or invest.